Advertisement

How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population?

      Abstract

      We evaluate the ability of the metabolic syndrome (MetS) defined by five definitions for predicting both incident CHD and diabetes combined, diabetes alone, and CHD alone in a Chinese population. The screening survey for type 2 diabetes was conducted in 1994. A follow-up study of 541 high-risk non-diabetic individuals who were free of CHD at baseline was carried out in 1999 in Beijing area. The MetS was defined by the World Health Organization (WHO), European Group for the Study of Insulin Resistance (EGIR), American College of Endocrinology (ACE), the International Diabetes Federation (IDF), and the National Cholesterol Education Program and the American Heart Association (AHA) (updated NCEP) criteria. From a multiple logistic regression adjusting for age, sex, education, occupation, smoking, family history of diabetes, and total cholesterol, the relative risk of the ACE-defined MetS for incident diabetes alone (67 cases) was 2.29 (95% CI, 1.20–4.34). The MetS defined by the five definitions was associated with a 1.8–3.9 times increased risk for both incident CHD and diabetes combined (59 cases), and with a 1.9–3.0 times for total incident diabetes (126 cases). None of the five definitions predicted either incident CHD alone (177 cases) or total incident CHD (236 cases).
      In conclusion, the MetS defined by the current definitions appears to be more effective at predicting incident diabetes.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Reaven G.M.
        Banting lecture 1988. Role of insulin resistance in human disease.
        Diabetes. 1988; 37: 1595-1607
        • DeFronzo R.A.
        • Ferrannini E.
        Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
        Diabetes Care. 1991; 14: 173-194
        • Parker L.
        • Lamont D.W.
        • Unwin N.
        • et al.
        A lifecourse study of risk for hyperinsulinaemia, dyslipidemia and obesity (the central metabolic syndrome) at age 49–51 years.
        Diabet Med. 2003; 20: 406-415
        • Freeman M.S.
        • Mansfield M.W.
        • Barrett J.H.
        • et al.
        Heritability of features of the insulin resistance syndrome in a community-based study of healthy families.
        Diabet Med. 2002; 19: 994-999
      1. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes and Mellitus. Geneva, World Health Organization 1999; (publ. no. WHO/NCD/NCS/99.2) Web site: http://www.whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2.pdf.

        • Balkau B.
        • Charles M.A.
        Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR).
        Diabet Med. 1999; 16: 442-443
        • National Institute of Health
        Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
        • Einhorn D.
        • Reaven G.M.
        • Cobin R.H.
        • et al.
        American College of Endocrinology position statement on the insulin resistance syndrome.
        Endocr Pract. 2003; 9: 237-252
        • Alberti K.G.
        • Zimmet P.
        • Shaw J.
        The metabolic syndrome—a new worldwide definition.
        Lancet. 2005; 366: 1059-1062
        • Grundy S.M.
        • Cleeman J.I.
        • Daniels S.R.
        • et al.
        Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.
        Circulation. 2005; 112: 2735-2752
        • Lakka H.M.
        • Laaksonen D.E.
        • Lakka T.A.
        • et al.
        The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
        JAMA. 2002; 288: 2709-2716
        • Hu G.
        • Qiao Q.
        • Tuomilehto J.
        • et al.
        Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women.
        Arch Intern Med. 2004; 164: 1066-1076
        • Malik S.
        • Wong N.D.
        • Franklin S.S.
        • et al.
        Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
        Circulation. 2004; 110: 1245-1250
        • Laaksonen D.E.
        • Lakka H.M.
        • Niskanen L.K.
        • et al.
        Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.
        Am J Epidemiol. 2002; 156: 1070-1077
        • Lorenzo C.
        • Okoloise M.
        • Williams K.
        • Stern M.P.
        • Haffner S.M.
        The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
        Diabetes Care. 2003; 26: 3153-3159
        • Resnick H.E.
        • Jones K.
        • Ruotolo G.
        • et al.
        Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in non-diabetic American Indians: the Strong Heart Study.
        Diabetes Care. 2003; 26: 861-867
        • McNeill A.M.
        • Rosamond W.D.
        • Girman C.J.
        • et al.
        The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study.
        Diabetes Care. 2005; 28: 385-390
        • Rutter M.K.
        • Meigs J.B.
        • Sullivan L.M.
        • D’Agostino Sr., R.B.
        • Wilson P.W.
        C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
        Circulation. 2004; 110: 380-385
        • Bonora E.
        • Kiechl S.
        • Willeit J.
        • et al.
        Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study.
        Diabetes Care. 2003; 26: 1251-1257
        • Stern M.P.
        • Williams K.
        • Gonzalez-Villalpando C.
        • Hunt K.J.
        • Haffner S.M.
        Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?.
        Diabetes Care. 2004; 27: 2676-2681
        • Pan X.R.
        • Yang W.Y.
        • Li G.W.
        • Liu J.
        Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group.
        Diabetes Care. 1997; 20: 1664-1669
        • Wang J.J.
        • Qiao Q.
        • Miettinen M.E.
        • Lappalainen J.
        • Hu G.
        • Tuomilehto J.
        The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high post-prandial glucose.
        Diabetes Care. 2004; 27: 2429-2437
        • Blackburn H.
        • Keys A.
        • Simonson E.
        • Rautaharju P.
        • Punsar S.
        The electrocardiogram in population studies. A classification system.
        Circulation. 1960; 21: 1160-1175
        • Pan X.R.
        • Hu Y.H.
        • Li G.W.
        • Liu P.A.
        • Bennett P.H.
        • Howard B.
        Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study.
        Diabetes Care. 1993; 16: 150-156
        • Gu D.
        • Reynolds K.
        • Wu X.
        • et al.
        Prevalence of the metabolic syndrome and overweight among adults in China.
        Lancet. 2005; 365: 1398-1405
        • Ford E.S.
        • Giles W.H.
        • Dietz W.H.
        Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.
        JAMA. 2002; 287: 356-359
        • Sharrett A.R.
        • Coady S.A.
        • Folsom A.R.
        • Couper D.J.
        • Heiss G.
        Smoking and diabetes differ in their associations with subclinical atherosclerosis and coronary heart disease-the ARIC Study.
        Atherosclerosis. 2004; 172: 143-149
        • Curb J.D.
        • Abbott R.D.
        • Rodriguez B.L.
        • et al.
        Prospective association between low and high total and low-density lipoprotein cholesterol and coronary heart disease in elderly men.
        J Am Geriatr Soc. 2004; 52: 1975-1980
        • Wang J.J.
        • Hu G.
        • Miettinen M.E.
        • Tuomilehto J.
        The metabolic syndrome and incident diabetes: assessment of four suggested definitions of the metabolic syndrome in a Chinese population with high post-prandial glucose.
        Horm Metab Res. 2004; 36: 708-715
        • Zhou B.F.
        Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults—study on optimal cut-off points of body mass index and waist circumference in Chinese adults.
        Biomed Environ Sci. 2002; 15: 83-96
        • Ko G.T.
        • Chan J.C.
        • Cockram C.S.
        • Woo J.
        Prediction of hypertension, diabetes, dyslipidemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese.
        Int J Obes Relat Metab Disord. 1999; 23: 1136-1142
        • Zhang X.
        • Shu X.O.
        • Gao Y.T.
        • et al.
        Anthropometric predictors of coronary heart disease in Chinese women.
        Int J Obes Relat Metab Disord. 2004; 28: 734-774